Abstract
Objective:
Randomized clinical trials of augmentation strategies for youth with treatment-resistant anxiety disorders do not exist. We present findings from an efficacy trial of attention bias modification treatment (ABMT) as an augment for this population, in comparison with attention control training (ACT).
Method:
Sixty-four youths (34 boys; M age=11.7 years) who continued to meet for anxiety diagnoses after completing cognitive behavior therapy (CBT) were randomized to either ABMT or ACT. ABMT and ACT consisted of dot-probe attention training trials presenting angry and neutral faces; probes appeared in the location of neutral faces on 100% of trials in ABMT and 50% of trials in ACT. Independent evaluators, youths, and parents completed ratings of youth anxiety severity, and youths completed measures of attention bias to threat and attention control at pretreatment, posttreatment, and two-month follow-up.
Results:
Both arms produced significant reductions in anxiety severity, with no differences between arms. Specifically, across informants, anxiety severity was significantly reduced at posttreatment and reductions were maintained at follow-up. Primary anxiety disorder diagnostic recovery combined across arms was 50% at posttreatment and 58% at follow-up. Attention control, but not attention bias to threat, was significantly improved at posttreatment in both arms.
Conclusion:
This is the first study to show anxiety can be reduced in youth who did not respond to CBT, and that anxiety-reducing effect is found using both attention training contingency schedules. These findings, along with increases in attention control in both arms, raise intriguing questions about mechanisms of anxiety reduction in treatment-resistant youth with attention training that require further research.
Keywords: anxiety, children, treatment, attention bias modification
Introduction
Cognitive behavioral therapy (CBT) is the strongest evidence-based psychosocial treatment for anxiety disorders in children and adolescents (hereon referred to as youth).1 Nevertheless, up to 50% of youth with anxiety disorders do not respond to CBT.1,2 No randomized controlled efficacy trials of treatment augmentation strategies for treatment-resistant anxious youth exist. There is critical need to have alternative treatments available for this population given that anxiety is associated with significant distress and impairment in functioning and poses substantial burden on the health-care system.3
This article reports the first randomized controlled efficacy trial that tests an augmentation strategy for youths who continued to meet for a Diagnostic and Statistical Manual of Mental Disorders-4th Edition (DSM-IV)4 anxiety disorder, despite having completed 12 to 14 sessions of CBT. The augmentation strategy we tested was attention bias modification treatment (ABMT), given its promise for youths who fail to respond to CBT. Relevant background to note is that attentional processes amongst individuals with anxiety disorders, including youth, are characterized by perturbations in rapidly deployed attention allocation to threat.5,6 Further, perturbations in attention allocation to threat predict youth’s poor response to CBT.7 In ABMT, attention perturbations are therefore targeted directly when patients complete hundreds of computer-based training trials of a dot-probe task. In each trial, a pair of threatening and neutral stimuli is presented simultaneously, followed immediately by a probe. The probe appears 100% of the time in the location of the neutral stimulus, establishing a contingency between neutral stimulus and probe location, facilitating reductions in attention allocation to threat. Meta-analyses demonstrate a significant small to medium effect of ABMT for anxiety disorders over various controls.8–10
ABMT is therefore a promising augment to CBT especially because each approach has a distinct emphasis. CBT’s emphasis is on top-down strategies for anxiety reduction in its use of explicit instruction and practice in effortful strategies such as cognitive restructuring and exposure to feared stimuli. ABMT’s emphasis is on bottom-up strategies for anxiety reduction in its use of implicit training of early, automatic attention allocation.11–13 Accordingly, ABMT’s constrained and intensive training to reduce attention to threat leads to diminished engagement of neural circuity and downstream cognitive-affective processes that subserve anxiety, resulting in anxiety reduction.13 Targeting bottom-up processes may be of particular importance in youth for whom top-down strategies were previously unsuccessful.
In the commonly-used comparison arm, Attention Control Training (ACT), youth complete the same dot-probe task as in ABMT, with the important exception that the probe appears with equal frequency in the locations of the neutral stimulus and threatening stimulus. By having no contingency between stimulus valence and probe location, ACT was designed to control for nonspecific effects on attention focusing, sustaining, and shifting. These features of ACT allow for disentangling and testing the training of attention away from threat as a mechanism of ABMT’s anxiety reduction effects.
Randomized controlled trial (RCT) data support ABMT’s efficacy in reducing anxiety in clinically anxious samples of youths.8,14 However, data from only one very small open trial with treatment-resistant anxiety disorders exist.15 Specifically, in six youths who completed CBT and still met for anxiety disorder diagnoses, ABMT reduced youth anxiety severity on both youth and parent ratings.15 We built on these preliminary data in the present study by conducting a RCT of ABMT and ACT in a larger treatment-resistant sample. Based on the training contingencies in ABMT, we hypothesized that ABMT, compared with ACT, would result in significantly lower levels of attention bias to threat and anxiety severity as rated by independent evaluators (IEs), youths, and parents at posttreatment (POST), and a follow-up evaluation two months after treatment (FOLLOW-UP). That is, we expected between-group contrasts to be statistically significant at POST and FOLLOW-UP, indicating lower attention bias to threat and anxiety severity in ABMT, compared with ACT.
Although ACT was designed initially as a comparator control arm, data have recently emerged suggesting attention control improvement via this comparator is a possible mechanism of anxiety reduction. ABMT and ACT both have been shown to produce increases in attention control, and reductions in anxiety, suggesting repeated practice on attention training protocols reduces anxiety.16,17 This is because attention control improvements relate to the ability for individuals to focus, sustain, and flexibly deploy attention to modulate anxious thoughts and feelings.12,16,18 ABMT and ACT both require participants to focus, sustain, and shift their attention over hundreds of trials, leading to increases in attention control. Based on these recent data, we hypothesized that levels of attention control would be significantly higher, and levels of anxiety severity significantly lower, at POST and FOLLOW-UP, relative to pretreatment (PRE), in both ABMT and ACT. That is, we expected the within-group effect of time to be statistically significant, indicating higher attention control and lower anxiety severity at POST and FOLLOW-UP, compared with PRE, in both ABMT and ACT.
Finally, we explored attention control as a moderator of ABMT’s anxiety reduction effects. Two clinical trials of ABMT in youths with anxiety disorders found attention control moderated anxiety reduction effects, although the direction of the moderation differed between studies.19,20 This could be because youths with lower regulatory ability benefit more from an intervention that targets bottom-up attention bias to threat than youths with higher attention control.19 Alternatively, youths with higher regulatory ability may assimilate the attention training more than youths with lower attention control.20 Given these contradictory findings, we took an exploratory approach to analysis of attention control as a moderator.
Method
Participants
We recruited participants from youths ages 7 to 16 years (mean age = 11.7 years, SD = 2.43; 53.1% boys; 85.9% Hispanic) who previously completed CBT for anxiety disorders in a separate clinical trial (ClinicalTrials.gov identifier: NCT01819311) or general clinic services, and continued to meet criteria for a primary DSM-IV anxiety disorder diagnosis at the conclusion of CBT and a one-year follow-up evaluation.4 The criterion of a diagnosis at one-year follow-up ensured all participants were non-responders, and were not delayed responders. The most common primary diagnoses at PRE of the present study were social anxiety disorder (39.1%), generalized anxiety disorder (31.3%), specific phobia (14.1%), and separation anxiety disorder (9.4%). Exclusion criteria were developmental disabilities, psychosis, or current involvement in another psychosocial treatment. See Procedures for a brief description of the manualized CBT and CBT outcomes.
As shown in Figure 1, 75 youths were eligible and recruited for this study. Of these 75 youths, 64 (85.3%) youths and their parents agreed to participate, provided informed parental consent and youth assent, and enrolled in the study. Of these 64 youths, 56 (87.5%) completed CBT in the clinical trial and 8 (12.5%) in general clinic services. There were no statistically significant differences on sociodemographic or clinical variables between the two subsamples.
Figure 1.
CONSORT Diagram
Note: ABMT = attention bias modification treatment; ACT = attention control training.
Materials and Task
We administered the Anxiety Disorder Interview Schedule for Children-IV: Child and Parent Versions (ADIS-IV: C/P)21 to youths and parents, respectively, to determine diagnoses. The disorder most interfering/impairing was primary. The ADIS-IV: C/P yields retest reliability kappas between .80 and .92 for diagnoses, interrater reliability kappas between .57 and .86 for specific anxiety diagnoses, and significant associations with youth anxiety ratings.22–24 In this study, we collected interrater reliability on diagnoses in 25% of participants; kappa coefficients were 1.0 for social anxiety disorder, 1.0 for generalized anxiety disorder, .63 for specific phobia, and .86 for separation anxiety disorder.
Outcomes.
We measured primary outcome using IE ratings of youth anxiety symptom severity on the six-item version of the Pediatric Anxiety Rating Scale (PARS).25 IEs administered and scored the PARS in accordance with the instructions provided by PARS developers.25 Specifically, using information obtained in separate interviews with youths and parents, an IE masked to participants’ assigned study arm scored each of 50 anxiety symptoms as either present or absent during the past week. IEs then rated endorsed symptoms on six dimensions of global severity and impairment. The PARS has adequate internal consistency (alpha coefficients between .64 and .91) and interrater reliability (intraclass correlation coefficients between .78 and .97), sensitivity to change in treatment studies, and convergent validity through significant correlations with youth self-ratings and parent ratings on youth anxiety scales.25,26 In this sample, the alpha coefficient for the six-item PARS was .77.
We measured secondary outcomes using youth self-ratings and parent ratings of youth anxiety symptom severity on the Screen for Child Anxiety Related Emotional Disorders – Child and Parent versions (SCARED–C/P).27 The SCARED-C/P consists of 41 items on which youth or parents rate youth anxiety symptoms. The SCARED-C/P has adequate test-retest reliability (ranging from .70 to .90) and convergent and divergent validity through expected patterns of correlations with other screening scales.27 In this sample, the alpha coefficient was .93 for the SCARED-C and .92 for the SCARED-P.
Attention Control.
We measured youth attention control using the Attentional Control Scale for Children (ACS-C).28 The ACS-C consists of 20 items on which youth rate their ability to maintain attention on a stimulus and shift attention from one stimulus to another. The ACS-C has demonstrated good psychometric properties and convergent validity compared with performance on tests of selective attention, attentional switching, and sustained attention,29 as well as higher levels of anxiety severity.30 In this sample, the alpha coefficient was .70.
Dot-Probe Task.
We used the emotional faces dot-probe task from the Tel Aviv University – NIMH ABMT Initiative (http://people.socsci.tau.ac.il/mu/anxietytrauma/research/) to measure attention bias towards threatening stimuli.31 Facial stimuli were photographs of 10 White actors (five men, five women), with two photographs of each actor (one neutral, one angry). In each trial, a white fixation cross appeared for 500 milliseconds (ms) in the center of the screen, followed by a pair of faces (chromatic) appearing for 500 ms. The pair of faces of the same actor showing a neutral or angry (i.e., threatening) expression appeared on the top and bottom of the screen. In each trial, the pair of faces displayed was one of two combinations (80 angry-neutral or 40 neutral-neutral) for a total of 120 trials. Immediately following the faces, a probe (“<“ or “>“) appeared in the location of either the top or bottom face. Participants were instructed to indicate the orientation of the probe by clicking the left or right mouse button (left for “<“, right for “>“) using their dominant hand. The probe remained on-screen until the participant responded, response was followed by an inter-trial interval (500 ms), and then the next trial began immediately. Angry face location, probe location, probe type, and actor were fully counterbalanced in presentation.
Responses on the dot-probe task were used to calculate attention bias scores. Trials in which the probe replaced the angry face were considered congruent trials, and trials in which the probe replaced the neutral face were considered incongruent trials. Bias scores were computed as reaction time differences of incongruent minus congruent trials. Positive attention bias scores indicate a bias toward angry faces (i.e., threat) and negative values indicate a bias away from threat. Inaccurate responses, trials with response latencies <150 ms and >1200 ms, and trials with response latencies +/− 2.5 SDs from the participant’s mean were excluded.32
Procedure
Previous CBT.
All participants in the current trial had previously received manualized CBT. CBT, in both the clinical trial and general clinic services, was administered in a youth anxiety disorders specialty research university clinic by the same trained therapists, supervised by the first and/or last author; for details on CBT administration, see33. Participants met criteria for a primary DSM-IV anxiety disorder diagnosis one year following their CBT participation.4 Pediatricians, school psychologists, and other professionals were major referral sources for the CBT for these youths.
The manualized CBT involved 12 to 14 weekly sessions of 60 minutes in duration.33 CBT targeted youth anxious symptoms, with initial sessions focused on psychoeducation, and with emphasis placed on graded exposures to feared or anxiety-provoking stimuli and cognitive restructuring. CBT sessions were video recorded and were carefully supervised by either the first or last author. IEs, not involved in the study, rated a randomly selected 30 videotaped sessions from the clinical trial on a checklist derived from past studies that assessed the presence of the ingredients that were expected to be delivered in accordance with the manual.23 Adherence to the manual was rated as 96.6%.
At the conclusion of the youths receiving CBT and again at a one-year follow-up evaluation, 32% of youths continued to meet criteria for a primary DSM-IV anxiety disorder diagnosis (i.e., 68% were recovered).4 The effect size for reductions in youth anxiety symptom severity following the conclusion of CBT was Cohen’s d = 0.78 for youth self-ratings and Cohen’s d = 0.92 for parent ratings. There were no significant differences between the clinical trial and general clinic services. This diagnostic recovery rate and magnitude of anxiety symptom severity reduction is comparable to previous clinical trials of CBT for youth with anxiety disorders, attesting to the proper implementation of CBT.2,23,34,35
Present Study.
The present study received human ethics approval from the university’s institutional review board (ClinicalTrials.gov identifier: NCT01819311). The study was conducted at Florida International University from April 2013 to June 2017. As noted, we recruited for this study all youths ages 7 to 16 years who continued to meet criteria for a primary DSM-IV anxiety disorder diagnosis at the conclusion of CBT and a one-year follow-up evaluation.4 All measures were completed at PRE, POST, and FOLLOW-UP two months after POST. Following PRE, participants were randomized in equal proportion to either ABMT or ACT. Participants and researchers were masked to study arm assignment. Before conducting interviews, IEs received extensive training in administration and scoring protocol and met 100% reliability criteria on five videotaped child–parent assessments. Doctoral level psychology graduate students administered ABMT and ACT sessions.
ABMT.
Consistent with past ABMT studies, youths completed two weekly sessions of ABMT over four weeks, for a total of eight sessions.15,19,36 At each session, participants completed 160 trials of the ABMT protocol. Trials of the ABMT protocol were identical to trials of the attention bias to threat assessment task except that a unique set of faces was used (i.e., different from those used in the assessment task) and the probe replaced the neutral face on 100% of the trials.
ACT.
ACT was identical to the ABMT protocol except for the frequency with which the probe replaced the neutral face. Eighty percent of trials included one neutral face and one angry face. On these trials, angry face location, probe location, and actor were fully counterbalanced. Probe type appeared with equal probability for angry face location, probe location, and actor. The other 20% of trials included neutral-neutral face pairs.
Statistical Analysis
To examine the influence of treatment on anxiety variables and attention variables, we used two-way analyses of covariance in a structural equation modeling (SEM) framework.37 In each model, participant age, CBT arm (clinical trial or general clinic services), and the PRE-score on the outcome variable were included as covariates. Likelihood ratio tests were used to examine differences between PRE and POST mean scores and POST and FOLLOW-UP mean scores for anxiety and attention variables (collapsing across treatment arms). To examine the associations between changes in anxiety variables and changes in attention variables, we used fixed effects regression analyses for panel data at PRE, POST, and FOLLOW-UP.38 This approach regressed anxiety variables onto attention variables on a within-person basis, documenting how much anxiety changed given a one unit change in attention variables. Non-model and model-based outlier analyses were undertaken. Two outliers were found. Analyses were conducted with and without the outliers and conclusions did not change. We present results for analyses conducted with the outliers to better represent the population of interest. We used a maximum likelihood estimator with robust standard errors (MLR) as implemented in the MPlus 6.12 statistical software program. To examine missing data bias, a dummy variable was created that indicated the presence or absence of missing data on each variable in the analyses. Associations between the dummy variables and other study variables were examined. No meaningful bias was observed. Missing data were accommodated using full information maximum likelihood.39 Modified linear probability models were used to examine probability differences between treatment arms on diagnostic recovery rates at POST and Follow Up.40,41 Across all analyses, significant effects were detected at a α ≤ 0.05. All tests were two-sided.
Results
There were no meaningful differences at PRE between participants in ABMT and participants in ACT on any study variables, including sociodemographic variables, primary diagnosis, and scores on any of the anxiety or attention variables (Tables 1 and 2). Of the 64 youths who were randomized, 61 completed the assigned treatment arm [60 (93.8%) completed all 8 sessions, 1 (1.6%) completed 7 sessions], 59 (92.2%) completed POST, and 52 (81.3%) completed FOLLOW-UP. Attrition did not significantly differ across study arms at POST or FOLLOW-UP. There were no statistically significant differences between study completers and non-completers at PRE on any study variables. Outcome analyses included both study completers and non-completers. We determined maintenance of masked assignment to study arm by asking youths and their parents at FOLLOW-UP to indicate to which study arm the youth was assigned (ABMT or ACT). Youths’ and parents’ ability to identify study arm assignment did not exceed chance.
Table 1.
Participant Sociodemographic and Diagnostic Characteristics at Pretreatment
| ABMT (n = 33) | ACT (n = 31) | |
|---|---|---|
| Age, mean (SD) | 12.18(2.69) | 11.26 (2.16) |
| Female gender, n (%) | 18 (54.5) | 12 (38.7) |
| Hispanic ethnicity, n (%) | 28 (84.8) | 27 (87.1) |
| Annual family income, n (%) | ||
| 0–20,999 | 7 (21.2) | 6 (19.4) |
| 21,000–60,999 | 8 (24.2) | 11 (35.5) |
| 61,000–99,999 | 9 (27.3) | 5 (16.3) |
| Over 100,000 | 6 (18.2) | 7 (22.6) |
| Not reported | 3 (9.1) | 2 (6.5) |
| Primary diagnosis, n (%) | ||
| Social Anxiety Disorder | 13 (39.4) | 12 (38.7) |
| Generalized Anxiety Disorder | 11 (33.3) | 9 (29.0) |
| Specific Phobia | 6 (18.2) | 3 (9.7) |
| Separation Anxiety Disorder | 2 (6.1) | 4 (12.9) |
| Other | 1 (3.0) | 3 (9.7) |
Note. ABMT = attention bias modification treatment; ACT = attention control training.
Table 2.
Means and SDs for Anxiety Symptoms and Attention Variables at Pretreatment, Posttreatment, and Two-Month Follow-up
| Measure | ABMT (n = 33) | ACT (n = 31) | |
|---|---|---|---|
| PARS | Pre | 14.55 (3.57) | 13.12 (3.83) |
| Post | 8.92 (5.51) | 8.23 (4.99) | |
| Follow-up | 9.38 (6.04) | 5.77 (4.44) | |
| SCARED-C | Pre | 23.03 (12.61) | 22.87 (15.39) |
| Post | 14.15 (12.55) | 12.83 (13.37) | |
| Follow-up | 17.40 (15.51) | 13.78 (12.93) | |
| SCARED-P | Pre | 27.74 (14.34) | 26.24 (12.26) |
| Post | 22.22 (13.98) | 18.05 (12.28) | |
| Follow-up | 21.47 (13.48) | 17.13 (12.58) | |
| Attention bias to threat | Pre | 3.21 (34.61) | 1.65 (42.81) |
| Post | −2.80 (63.66) | 14.61 (58.35) | |
| Follow-up | 15.17 (36.78) | 12.08 (36.23) | |
| ACS-C | Pre | 52.05 (7.46) | 50.58 (7.25) |
| Post | 55.65 (9.31) | 53.80 (10.48) | |
| Follow-up | 54.71 (9.46) | 53.41 (9.32) |
Note. Means and SDs of attention bias to threat are presented in milliseconds. ABMT = attention bias modification treatment; ACT = attention control training; ACS-C = Attentional Control Scale for Children; PARS = Pediatric Anxiety Rating Scale; SCARED – C = Screen for Child Anxiety and Related Disorders – Child Version; SCARED-P = Screen for Child Anxiety and Related Disorders – Parent Version.
Outcomes Analyses
We present means and standard deviations on anxiety variables and attention variables for each study arm in Table 2. Collapsing across study arms, mean total scores were significantly lower at POST than PRE for the PARS (z=6.10, p<.001; Cohen’s d=1.21), SCARED-C (z=5.24, p<.001; Cohen’s d=0.88), and SCARED-P (z=3.96, p<.001; Cohen’s d=0.67). Mean scores at POST were not significantly different from mean scores at FOLLOW-UP for the PARS or SCARED-C. For the SCARED-P, mean total scores were significantly lower at FOLLOW-UP than POST (z=2.34, p=.02; Cohen’s d=0.34). There were no significant differences between study arms at POST or FOLLOW-UP for the PARS (z=−.08, p=.94; z=.92, p=.36), SCARED-C (z=1.23, p=.22; z=1.62, p=.10), or SCARED-P (z=1.76, p=.08; z=−.04, p=.97).
At POST, the primary anxiety disorder diagnostic recovery rate was 39% in ABMT and 60% in ACT. At FOLLOW-UP, the primary anxiety disorder diagnostic recovery rate was 50% in ABMT and 65% in ACT. No significant differences in diagnostic recovery rates were found between arms at POST (z=1.50, p=.14) or FOLLOW-UP (z=1.01, p=.31). Across arms, the primary anxiety disorder diagnostic recovery rate was 50% at POST and 58% at FOLLOW-UP.
Attention Bias and Attention Control Analyses
Collapsing across study arms, mean attention bias scores did not significantly differ between PRE and POST, nor between POST and FOLLOW-UP. There were no significant differences between study arms on mean attention bias scores at POST (z=−1.14, p=.25) or FOLLOW-UP (z=.05, p=.96). In fixed effects panel regression analyses, changes in attention bias scores were not significantly associated with changes in anxiety severity. Given past data showing patterns of attention bias may change with youth age,5 we explored the association between age and attention bias and also explored age as a moderator of change in attention bias. Significant age effects were not found in these analyses.
Collapsing across study arms, mean attention control scores on the ACS-C were significantly higher at POST than PRE (z=3.51, p<.001; Cohen’s d=0.42). The mean ACS-C score at POST was not significantly different from the mean score at FOLLOW-UP. There were no significant differences between study arms on mean ACS-C scores at POST (z=−.41, p=.68) or FOLLOW-UP (z=.54, p=.59). Examination of ACS-C scores at PRE as a moderator of anxiety reduction effects yielded no statistically significant effects. In fixed effects panel regression analyses, changes in ACS-C scores were not significantly associated with changes in anxiety severity on the PARS or SCARED-P. The coefficient for the SCARED-C was at a trend level (coefficient=−0.23, z=−1.93, p=.05), indicating that for every one unit increase in ACS-C, SCARED-C scores decreased on average by 0.23 units.
Discussion
In this sample of youths with CBT-resistant anxiety disorders, we found statistically significant anxiety reductions from PRE to POST, with medium to large effect sizes across IE ratings, youth self-ratings, and parent ratings. Further, 50% of youths no longer met criteria for their primary anxiety diagnosis at POST. These anxiety reductions and diagnostic recovery effects were maintained at a two-month FOLLOW-UP. These are the first data to demonstrate successful anxiety reduction effects in youths who had previously failed to respond to treatment.
These are also the first data to show ABMT and ACT did not differ significantly in a sample of youths with treatment-resistant anxiety disorders. That is, we found medium to large anxiety reduction effects and diagnostic recovery in both arms. The absence of between-groups differences was unexpected because meta-analyses demonstrate a significant though not large effect of ABMT compared with ACT.8–10 However, the presence of within-group anxiety reduction effects in both ABMT and ACT was expected and is consistent with a recent review of 31 trials of ABMT and ACT.42 A majority of trials included in the review found anxiety reduction effects in both ABMT and ACT. This suggests a common mechanism or mechanisms may contribute to anxiety reduction effects in each of these attention training protocols.
Emerging evidence suggests that improvements in attention control may provide insight into a common mechanism. Consistent with other recent trials of ABMT,16,17 youths in both arms showed increases in attention control. Further, every one-unit increase in attention control was associated with a 0.23-unit decrease in youth self-ratings on anxiety severity. These findings suggest that both attention training protocols (i.e., 100% to neutral in ABMT; 50% to neutral in ACT) may increase attention control and thereby reduce anxiety.12,18 This is because repeated practice focusing, sustaining, and shifting attention during training may lead to improvements in regulatory abilities that enable youth to flexibly deploy attention to modulate their emotional experiences. It is also possible that repeated exposure to threatening stimuli in the context of attention training, as occurs in both ABMT and ACT, enhances anxiety reduction effects by increasing attention control specifically in the presence of a distracting threat.42
This latter possibility may be related to the slightly superior, albeit nonsignificant, effects observed in ACT compared with ABMT. Compared with ABMT, which establishes a contingency between threatening stimuli and probe location (i.e., the probe always appears in the location opposite threatening stimuli), ACT may train greater flexibility in the deployment of attention by requiring participants to ignore distracting threatening stimuli that are irrelevant to efficient completion of the task.43 More research is needed on the optimal attention training contingency schedules for enhancing attention control in youth with treatment-resistant anxiety disorders.
Participants’ expectations is another possible common mechanism for anxiety reduction to consider, especially given this is a unique sample, relative to past samples in ABMT trials. There are two sides of the coin to consider in this regard. On one side, these youths, who went through a CBT protocol, only to still be experiencing impairing anxiety upon completion, may have entered the novel computer-based attention training protocols with enhanced hope and expectation, contributing to the positive outcomes observed in both arms. If this side of the coin has merit, it suggests a striking example of the power of expectations (e.g., that 50% of these treatment-resistant youths showed diagnostic recovery at POST; 58% showed diagnostic recovery at FOLLOW-UP). The other side of the coin is that expectancy was not a major factor because the youths’ failure to respond to CBT may have in fact dampened their hopes and expectations. Further research using alternative comparators to permit study of expectancy effects vis-á-vis attention control and exposure to threatening stimuli will help clarify common and unique mechanisms underlying ABMT and ACT.
Of further note, we did not find statistically significant reductions in youths’ attention to threat as measured by reaction time scores on the dot-probe task. Studies have raised questions about the sensitivity of reaction time measures of attention bias to threat.44,45 Reaction time measures are several steps removed from the allocation of attention and thus are subject to inter-participant variability in downstream processes, including strategic decision making and motor response.45,46 Further, instability in reaction times may arise from ongoing interplay between top-down attention control processes and bottom-up attention alerting and orienting processes. Use of eye-tracking technology or neural responses to threat signals with more precise temporal resolution, such as event related potentials, may provide more sensitive measures of attention to threat in future studies.46,47 Studies have also raised questions about developmental influences on attention bias to threat.5 We did not find an association between age and attention to threat in this study or evidence that age moderated the effect of ABMT on attention to threat. Future studies that are sufficiently powered to test moderation could further explore age as a potential moderator.
In addition, in this first study of a clinical next step to allay treatment-resistant anxiety in youth, we sampled youths who showed treatment-resistant anxiety immediate following the conclusion of CBT and again at one-year follow-up. We adopted this approach to ensure our sample included “true” non-responders, not delayed responders who may improve in the weeks and months following CBT. Going forward, it will be important to identify non-responders earlier and initiate adjunctive treatment quickly instead of waiting until CBT has ended. We previously demonstrated an empirical approach to identifying youth anxiety non-responders by the midpoint of treatment.33 Further research with this and other approaches will be helpful to identify youth with treatment-resistant anxiety early and evaluate whether initiating adjunctive attention training with these youth will result in more rapid reductions in anxiety severity.
This study’s findings should be interpreted in view of its strengths and limitations. Strengths include the evaluation of treatment-resistant status a full year after CBT ended, the double-masked, randomized controlled design, the multi-informant assessment approach, and the follow-up evaluation to examine maintenance of effects two months after attention training ended. One limitation is the absence of a waitlist control or an alternative comparison arm. In the absence of such an arm, it is not possible to conclude that enhancements in attention control accounted for reductions in anxiety severity. A second limitation is the reliance on a rating scale to measure youth attention control. Future studies could include performance-based measures of attention control, such as the Attention Network Task48 or the Antisaccade Task.49 Finally, because the sample consisted of predominantly Hispanic/Latino participants, the generalizability of findings to other populations is unknown. We know of no theoretical or empirical reason to expect attention to threat to differ across racial or ethnic groups of youth. However, racial/ethnic minority status predicted a better response to attention training in a clinic referred sample of adults with anxiety disorders.50 Further research is needed on the association between youth race/ethnicity and response to attention training.
In spite of these limitations, these data demonstrate the promise of augmentation with attention training in youths who are treatment resistant to CBT. Indeed, 68% of these youths showed diagnostic recovery following the conclusion of CBT. Moreover, 50% of youths who continued to meet criteria for a primary anxiety disorder following CBT showed diagnostic recovery following four weeks of attention training. The result is an overall diagnostic recovery of 84% (i.e., 68% following CBT plus 16% following attention training). This diagnostic recovery rate is higher than rates reported in previous clinical trials of CBT alone or combined with sertraline, which ranged from approximately 45% to 75%.2,23,34,35 These are exciting, novel data that lay the groundwork for further innovative efforts to improve the outcomes of young people who suffer from anxiety disorders but are not responsive to CBT. The data also set the stage for further mechanistic research on attention training protocols, using alternative comparison arms.
Acknowledgments
This study was supported by National Institute of Mental Health grant R34MH097931. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Mental Health. Work by Drs. Abend and Pine was supported by the Intramural Research Program at the National Institute of Mental Health.
Dr. Jaccard served as the statistical expert for this research.
The authors gratefully acknowledge Yesenia Martinez, LMHC, Daniella Vaclavik, MS, Victor Buitron, MS, and Raquel Melendez, MS, of Florida International University, for their assistance in administering attention training sessions and collecting data.
Clinical trial registration information: Attention Bias Modification Training for Child Anxiety CBT Nonresponders; https://clinicaltrials.gov/; NCT01819311
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Disclosure: Dr. Pettit has received book royalties from the American Psychological Association and New Harbinger Publications. Dr. Silverman has received royalties as an author of the Anxiety Disorders Interview Schedule for Children. Drs. Bechor, Rey, Vasey, Abend, Pine, Bar-Haim, and Jaccard report no biomedical financial interests or potential conflicts of interest.
References
- 1.Higa-McMillan CK, Francis SE, Rith-Najarian L, Chorpita BF. Evidence base update: 50 years of research on treatment for child and adolescent anxiety. J Clin Child Adolesc. 2016;45(2):91–113. [DOI] [PubMed] [Google Scholar]
- 2.Silverman WK, Pina AA, Viswesvaran C. Evidence-based psychosocial treatments for phobic and anxiety disorders in children and adolescents. J Clin Child Adolesc. 2008;37(1):105–130. [DOI] [PubMed] [Google Scholar]
- 3.Snell T, Knapp M, Healey A, et al. Economic impact of childhood psychiatric disorder on public sector services in Britain: estimates from national survey data. J Child Psychol Psychiatry. 2013;54(9):977–985. [DOI] [PubMed] [Google Scholar]
- 4.American Psychiatric Association; Diagnostic and statistical manual of mental disorders (4thed.). Washington, DC: Author; 1994. [Google Scholar]
- 5.Dudeney J, Sharpe L, Hunt C. Attentional bias towards threatening stimuli in children with anxiety: A meta-analysis. Clin Psychol Rev. 2015;40:66–75. [DOI] [PubMed] [Google Scholar]
- 6.Abend R, de Voogd L, Salemink E, et al. Association between attention bias to threat and anxiety symptoms in children and adolescents. Depress Anxiety. 2018;35(3):229–238. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Legerstee JS, Tulen JHM, Kallen VL, et al. Threat-related selective attention predicts treatment success in childhood anxiety disorders. J Am Acad Child Psy. 2009;48(2):196–205. [DOI] [PubMed] [Google Scholar]
- 8.Price RB, Wallace M, Kuckertz JM, et al. Pooled patient-level meta-analysis of children and adults completing a computer-based anxiety intervention targeting attentional bias. Clin Psychol Rev. 2016;50:37–49. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Hakamata Y, Lissek S, Bar-Haim Y, et al. Attention bias modification treatment: a meta-analysis toward the establishment of novel treatment for anxiety. Biol Psychiatry. 2010;68(11):982–990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Linetzky M, Pergamin-Hight L, Pine DS, Bar-Haim Y. Quantitative evaluation of the clinical efficacy of attention bias modification treatment for anxiety disorders. Depress Anxiety. 2015;32(6):383–391. [DOI] [PubMed] [Google Scholar]
- 11.Clark DA, Beck AT. Cognitive theory and therapy of anxiety and depression: convergence with neurobiological findings. Trends Cogn Sci. 2010;14(9):418–424. [DOI] [PubMed] [Google Scholar]
- 12.Bar-Haim Y Research review: Attention bias modification (ABM): a novel treatment for anxiety disorders. J Child Psychol Psychiatry. 2010;51(8):859–870. [DOI] [PubMed] [Google Scholar]
- 13.White LK, Sequeira S, Britton JC, et al. Complementary features of attention bias modification therapy and cognitive-behavioral therapy in pediatric anxiety disorders. Am J Psychiatry. 2017;174(8):775–784. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Lowther H, Newman E. Attention bias modification (ABM) as a treatment for child and adolescent anxiety: A systematic review. J Affect Disorders. 2014;168:125–135. [DOI] [PubMed] [Google Scholar]
- 15.Bechor M, Pettit JW, Silverman WK, et al. Attention Bias Modification Treatment for children with anxiety disorders who do not respond to cognitive behavioral therapy: a case series. J Anxiety Disord. 2014;28(2):154–159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Heeren A, Mogoase C, McNally RJ, Schmitz A, Philippot P. Does attention bias modification improve attentional control? A double-blind randomized experiment with individuals with social anxiety disorder. J Anxiety Disord. 2015;29:35–42. [DOI] [PubMed] [Google Scholar]
- 17.McNally RJ, Enock PM, Tsai C, Tousian M. Attention bias modification for reducing speech anxiety. Behav Res Ther. 2013;51(12):882–888. [DOI] [PubMed] [Google Scholar]
- 18.Klumpp H, Amir N. Preliminary study of attention training to threat and neutral faces on anxious reactivity to a social stressor in social anxiety. Cognitive Ther Res. 2010;34(3):263–271. [Google Scholar]
- 19.Pergamin-Hight L, Pine DS, Fox NA, Bar-Haim Y. Attention bias modification for youth with social anxiety disorder. J Child Psychol Psychiatry. 2016;57(11):1317–1325. [DOI] [PubMed] [Google Scholar]
- 20.Ollendick TH, White SW, Richey JA, et al. Attention bias modification treatment for adolescents with social anxiety disorder. Behav Ther. 2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Silverman WK, Albano AM. Anxiety Disorders Interview Schedule for Children-IV (Child and Parent Versions). San Antonio, TX: Psychological Corporation; 1996. [Google Scholar]
- 22.Wood JJ, Piacentini JC, Bergman RL, McCracken J, Barrios V. Concurrent validity of the anxiety disorders section of the Anxiety Disorders Interview Schedule for DSM-IV: child and parent versions. J Clin Child Adolesc Psychol. 2002;31(3):335–342. [DOI] [PubMed] [Google Scholar]
- 23.Silverman WK, Kurtines WM, Jaccard J, Pina AA. Directionality of change in youth anxiety treatment involving parents: an initial examination. J Consult Clin Psych. 2009;77(3):474–485. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Silverman WK, Saavedra LM, Pina AA. Test-retest reliability of anxiety symptoms and diagnoses with the Anxiety Disorders Interview Schedule for DSM-IV: child and parent versions. J Am Acad Child Adolesc Psychiatry. 2001;40(8):937–944. [DOI] [PubMed] [Google Scholar]
- 25.RUPP Anxiety Study Group. The Pediatric Anxiety Rating Scale (PARS): development and psychometric properties. J Am Acad Child Adolesc Psychiatry. 2002;41(9):1061–1069. [DOI] [PubMed] [Google Scholar]
- 26.Walkup JT, Albano AM, Piacentini J, et al. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. New Engl J Med. 2008;359(26):2753–2766. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Birmaher B, Khetarpal S, Brent D, et al. The Screen for Child Anxiety Related Emotional Disorders (SCARED): scale construction and psychometric characteristics. J Am Acad Child Adolesc Psychiatry. 1997;36(4):545–553. [DOI] [PubMed] [Google Scholar]
- 28.Muris P, de Jong PJ, Engelen S. Relationships between neuroticism, attentional control, and anxiety disorders symptoms in non-clinical children. Pers Indiv Differ. 2004;37(4):789–797. [Google Scholar]
- 29.Muris P, Mayer B, van Lint C, Hofman S. Attentional control and psychopathological symptoms in children. Pers Indiv Differ. 2008;44(7):1495–1505. [Google Scholar]
- 30.Melendez R, Bechor M, Rey Y, Pettit JW, Silverman WK. Attentional Control Scale for Children: Factor structure and concurrent validity among children and adolescents referred for anxiety disorders. J Clin Psychol. 2017;73(4):489–499. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Abend R, Pine DS, Bar-Haim Y. The TAU-NIMH Attention Bias Measurement Toolbox. Available from: http://people.socsci.tau.ac.il/mu/anxietytrauma/research/. Accessed January 24, 2019.
- 32.Eldar S, Yankelevitch R, Lamy D, Bar-Haim Y. Enhanced neural reactivity and selective attention to threat in anxiety. Biol Psychol. 2010;85(2):252–257. [DOI] [PubMed] [Google Scholar]
- 33.Pettit JW, Silverman WK, Rey Y, Marin C, Jaccard J. Moving to second-stage treatments faster: identifying midtreatment tailoring variables for youth with anxiety disorders. J Clin Child Adolesc Psychol. 2016;45(4):457–468. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Ginsburg GS, Kendall PC, Sakolsky D, et al. Remission after acute treatment in children and adolescents with anxiety disorders: findings from the CAMS. J Consult Clin Psychol. 2011;79(6):806–813. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Kendall PC. Treating anxiety disorders in children: results of a randomized clinical trial. J Consult Clin Psychol. 1994;62(1):100–110. [DOI] [PubMed] [Google Scholar]
- 36.Pettit JW, Rey Y, Bechor M, et al. Can less be more? Open trial of a stepped care approach for child and adolescent anxiety disorders. J Anxiety Disord. 2017;51:7–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Rausch JR, Maxwell SE, Kelley K. Analytic methods for questions pertaining to a randomized pretest, posttest, follow-up design. J Clin Child Adolesc Psychol. 2003;32(3):467–486. [DOI] [PubMed] [Google Scholar]
- 38.Allison P Fixed effects regression modeling. Thousand Oaks, CA: Sage; 2009. [Google Scholar]
- 39.Enders CK. Applied missing data analysis. New York: Guilford Publications; 2010. [Google Scholar]
- 40.Hellevik O Linear versus logistic regression when the dependent variable is a dichotomy. Qual Quant. 2009;43(1):59–74. [Google Scholar]
- 41.Deke J Using the linear probability model to estimate impacts on binary outcomes in randomized controlled trials Mathematic Policy Research Reports 62a1477e274d429faf7e0c71b. 2014;Mathematica Policy Research. [Google Scholar]
- 42.Mogg K, Waters AM, Bradley BP. Attention bias modification (ABM): review of effects of multisession ABM training on anxiety and threat-related attention in high-anxious individuals. Clin Psychol Sci. 2017;5(4):698–717. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of Attention Training on Attention Bias Variability and PTSD Symptoms: Randomized Controlled Trials in Israeli and U.S. Combat Veterans. Am J Psychiatry. 2015;172(12):1233–1241. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Brown HM, Eley TC, Broeren S, et al. Psychometric properties of reaction time based experimental paradigms measuring anxiety-related information-processing biases in children. J Anxiety Disord. 2014;28(1):97–107. [DOI] [PubMed] [Google Scholar]
- 45.Price RB, Kuckertz JM, Siegle GJ, et al. Empirical recommendations for improving the stability of the dot-probe task in clinical research. Psychol Assess. 2015;27(2):365–376. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.MacNamara A, Kappenman ES, Black SR, Bress JN, Hajcak G. Integratived behavioral and electrocortical measures of attentional bias toward threat In: Barrett KC, Fox NA, Morgan GA, Fidler DJ, Daunhauer LA, eds. Handbook of self-regulatory processes in development: New directions and international perspectives New York: Psychology Press; 2013:215–243. [Google Scholar]
- 47.Bechor M, Ramos ML, Crowley MJ, Silverman WK, Pettit JW, Reeb-Sutherland BC. Neural correlates of attentional processing of threat in youth with and without anxiety disorders. J Abnorm Child Psychol. 2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Fan J, McCandliss BD, Sommer T, Raz A, Posner MI. Testing the efficiency and independence of attentional networks. J Cognitive Neurosci. 2002;14(3):340–347. [DOI] [PubMed] [Google Scholar]
- 49.Chen NT, Clarke PJ, Watson TL, MacLeod C, Guastella AJ. Attentional bias modification facilitates attentional control mechanisms: evidence from eye tracking. Biol Psychol. 2015;104:139–146. [DOI] [PubMed] [Google Scholar]
- 50.Amir N, Taylor CT, Donohue MC. Predictors of response to an attention modification program in generalized social phobia. J Consult Clin Psychol. 2011;79(4):533–541. [DOI] [PMC free article] [PubMed] [Google Scholar]

